These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8915517)

  • 1. Impaired CD25 expression and soluble CD25-IL-2R alpha receptor release by anti-CD3 stimulated peripheral blood mononuclear cells in Hodgkin's disease patients.
    Frydecka I; Mazur G
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):127-30. PubMed ID: 8915517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.
    Tesch H; Günther A; Abts H; Jücker M; Klein S; Krueger GR; Diehl V
    Am J Pathol; 1993 Jun; 142(6):1714-20. PubMed ID: 8506943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Soluble interleukin 2 receptor (sIL-2R) in patients with esophageal carcinoma].
    Duan ZF
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):17-9. PubMed ID: 8334935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble interleukin-2 receptor in vitro production by mononuclear cells from Hodgkin patients.
    Caruso C; Modica MA; Candore G; Di Giulio C; Galluzzo A; Giordano C; Di Marco P; Gebbia V; Tamone Reyes M; Citarrella P
    Boll Ist Sieroter Milan; 1990; 69(1):335-8. PubMed ID: 2102116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer.
    Macciò A; Lai P; Santona MC; Pagliara L; Melis GB; Mantovani G
    Gynecol Oncol; 1998 Jun; 69(3):248-52. PubMed ID: 9648596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease.
    Frydecka I; Boćko D; Kosmaczewska A; Ciszak L; Morilla R
    Br J Cancer; 2001 May; 84(10):1339-43. PubMed ID: 11355944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of soluble IL-2 receptor in the serum and bone marrow of patients with minimal residual hematological malignancies: induction under therapy with IL-2.
    Kandefer-Szerszeń M; Legieć W; Dmoszyńska A; Rzeski W
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):443-8. PubMed ID: 9437500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis related interleukin-2 receptor release by peripheral blood mononuclear cells.
    Memoli B; Libetta C; De Nicola L; Rampino T; Capuano A; Guida B; Andreucci VE
    ASAIO J; 1996; 42(1):60-3. PubMed ID: 8808460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-interferon and soluble interleukin 2 receptor in tuberculous pleural effusion.
    Kim YK; Lee SY; Kwon SS; Kim KH; Moon HS; Song JS; Park SH
    Lung; 2001; 179(3):175-84. PubMed ID: 11891607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble interleukin 2 receptor alpha and soluble CD8 levels in patients with gynecological malignancies undergoing radiotherapy.
    Frydecka I; Rusiecka M; Kuliczkowski K; Kornafel J
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):123-6. PubMed ID: 8915516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interleukin 1 production by peripheral blood mononuclear cells of children with bronchial asthma in remission].
    Ichikawa K; Baba M; Yoshizawa I; Kawano Y; Noma T
    Arerugi; 1995 Sep; 44(9):1132-9. PubMed ID: 8534209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
    Symons JA; Wood NC; Di Giovine FS; Duff GW
    J Immunol; 1988 Oct; 141(8):2612-8. PubMed ID: 3262665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transduction defect in the acquired immunodeficiency syndrome and AIDS-related complex.
    Gupta S
    Thymus; 1993 Sep; 22(2):83-90. PubMed ID: 8209399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of luteinizing hormone alpha-subunit on IL-2 and sIL-2R in vitro secretions from human peripheral blood mononuclear cells.
    Komorowski J; Gradowski G; Stepień H
    Cytobios; 1997; 89(356):31-7. PubMed ID: 9297814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum soluble IL-2 receptor level in patients with sarcoidosis].
    Ina Y; Takada K; Noda M; Satou T; Hashiba H; Miyachi A; Ito S; Iijima N; Yamamoto M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):316-21. PubMed ID: 2067152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
    Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
    Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
    Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
    Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of interleukin-2 receptor alpha (IL-2R alpha) mRNA and protein in advanced epithelial ovarian cancer.
    Barton DP; Blanchard DK; Wells AF; Nicosia SV; Roberts WS; Cavanagh D; Djeu JY
    Anticancer Res; 1994; 14(3A):761-72. PubMed ID: 8074478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.